Clinical Predictors of Diabetic Retinopathy Progression; A Systematic Review

Author(s): Abdul Hamid Al Ghamdi*.

Journal Name: Current Diabetes Reviews

Volume 16 , Issue 3 , 2020

Become EABM
Become Reviewer

Abstract:

Objective: This study was conducted to discuss the clinical value of published Diabetic Retinopathy Progression determinants.

Methods: The data for systematic review was collected from the published studies through PubMed and Medline. These studies discussed the clinical predictors of Diabetic Retinopathy (DR) progression. The common keywords used were diabetic Retinopathy, diabetes mellitus, systolic blood pressure, hemoglobin, and albuminuria.

Results: Diabetic Retinopathy is one of the common causes of irreversible visual impairment among adults. Poor glycemic control, systemic hypertension, diabetes duration, dyslipidemia, and microalbuminuria are the major risk factors for the development and progression of diabetic retinopathy. Recently, increased aortic stiffness has been identified as a prognostic marker of diabetic retinopathy and peripheral neuropathy.

Conclusion: Certain groups of diabetic individuals are at higher risk to have progressive diabetic retinopathy and eventually visual impairment. Clinical determinants and predictors are considered as prognostic markers and could help physicians to develop an effective risk-based screening program for this condition.

Keywords: Diabetic retinopathy, diabetes mellitus, systolic blood pressure, hemoglobin, albuminuria, systematic review.

[1]
Chew EY, Davis MD, Danis RP, et al. Action to Control Cardiovascular Risk in Diabetes Eye Study Research Group. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology 2014; 121(12): 2443-51.
[http://dx.doi.org/10.1016/j.ophtha.2014.07.019] [PMID: 25172198]
[2]
Pedro RA, Ramon SA, Marc BB, Juan FB, Isabel MM. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study. Ophthalmic Epidemiol 2010; 17(4): 251-65.
[http://dx.doi.org/10.3109/09286586.2010.498661] [PMID: 20642348]
[3]
Karoli R, Fatima J, Shukla V, Garg P, Ali A. Predictors of diabetic retinopathy in patients with type 2 diabetes who have normoalbuminuria. Ann Med Health Sci Res 2013; 3(4): 536-40.
[http://dx.doi.org/10.4103/2141-9248.122087] [PMID: 24380004]
[4]
Trento M, Charrier L, Salassa M, et al. Cognitive function may be a predictor of retinopathy progression in patients with type 2 diabetes. Eur J Ophthalmol 2017; 27(3): 278-80.
[http://dx.doi.org/10.5301/ejo.5000885] [PMID: 27716894]
[5]
Ra H, Yoo JH, Ban WH, et al. Predictors for diabetic retinopathy in normoalbuminuric people with type 2 diabetes mellitus. Diabetol Metab Syndr 2012; 4(1): 29.
[http://dx.doi.org/10.1186/1758-5996-4-29] [PMID: 22747972]
[6]
Jeng CJ, Hsieh YT, Yang CM, Yang CH, Lin CL, Wang IJ. Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression. PLoS One 2016; 11(8)e0161897
[http://dx.doi.org/10.1371/journal.pone.0161897] [PMID: 27564383]
[7]
Cardoso CRL, Leite NC, Dib E, Salles GF. Predictors of Development and Progression of Retinopathy in Patients with Type 2 Diabetes: Importance of Blood Pressure Parameters. Sci Rep 2017; 7(1): 4867.
[http://dx.doi.org/10.1038/s41598-017-05159-6] [PMID: 28687808]
[8]
Sternberg M, M’bemba J, Urios P, et al. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy. Clin Biochem 2016; 49(3): 225-31.
[http://dx.doi.org/10.1016/j.clinbiochem.2015.10.011] [PMID: 26506116]
[9]
Kuo JZ, Wong TY, Rotter JI. Challenges in elucidating the genetics of diabetic retinopathy. JAMA Ophthalmol 2014; 132(1): 96-107.
[http://dx.doi.org/10.1001/jamaophthalmol.2013.5024] [PMID: 24201651]
[10]
Jeng CJ, Hsieh YT, Yang CM, Yang CH, Lin CL, Wang IJ. Diabetic retinopathy in patients with dyslipidemia: Development and progression. Ophthalmol Retina 2018; 2(1): 38-45.
[http://dx.doi.org/10.1016/j.oret.2017.05.010] [PMID: 31047300]
[11]
Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye and visiom 2015; 2: 17.
[http://dx.doi.org/10.1186/s40662-015-0026-2]
[12]
Lewis AD, Hogg RE, Chandran M, et al. Prevalence of diabetic retinopathy and visual impairment in patients with diabetes mellitus in Zambia through the implementation of a mobile diabetic retinopathy screening project in the Copperbelt province: a cross-sectional studyEye. (London, England) 2018.
[http://dx.doi.org/10.1038/s41433-018-0055-x]
[13]
Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med 2009; 55(2): 92-6.
[http://dx.doi.org/10.4103/0022-3859.48787] [PMID: 19550052]
[14]
Wang B, Wang F, Zhang Y, et al. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015; 3(4): 263-74.
[http://dx.doi.org/10.1016/S2213-8587(14)70256-6] [PMID: 25660574]
[15]
Zhou MS, Schulman IH. Prevention of diabetes in hypertensive patients: results and implications from the VALUE trial. Vasc Health Risk Manag 2009; 5(1): 361-8.
[http://dx.doi.org/10.2147/VHRM.S4331] [PMID: 19475773]
[16]
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl. 1): S62-9.
[http://dx.doi.org/10.2337/dc10-S062] [PMID: 20042775]
[17]
Irace C, Scarinci F, Scorcia V, et al. Association among low whole blood viscosity, haematocrit, haemoglobin and diabetic retinopathy in subjects with type 2 diabetes. Br J Ophthalmol 2011; 95(1): 94-8.
[http://dx.doi.org/10.1136/bjo.2009.172601] [PMID: 20530659]
[18]
Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4. Diabet Med 2008; 25(5): 536-42.
[http://dx.doi.org/10.1111/j.1464-5491.2008.02423.x] [PMID: 18346159]
[19]
Li-Rumei and Hu-Renming. Diabetic Retinopathy. Avid Science Publications 2017.
[20]
Harris Nwanyanwu K, Talwar N, Gardner TW, Wrobel JS, Herman WH, Stein JD. Predicting development of proliferative diabetic retinopathy. Diabetes Care 2013; 36(6): 1562-8.
[http://dx.doi.org/10.2337/dc12-0790] [PMID: 23275374]
[21]
Gerstein HC, Ambrosius WT, Danis R, et al. ACCORD Study Group. Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. Diabetes Care 2013; 36(5): 1266-71.
[http://dx.doi.org/10.2337/dc12-1311] [PMID: 23238658]
[22]
Hsieh YM, Lee WJ, Sheu WH, Li YH, Lin SY, Lee IT. Inpatient screening for albuminuria and retinopathy to predict long-term mortality in type 2 diabetic patients: a retrospective cohort study. Diabetol Metab Syndr 2017; 9: 29.
[http://dx.doi.org/10.1186/s13098-017-0229-x] [PMID: 28473872]
[23]
Salles GF, Leite NC, Pereira BB, Nascimento EM, Cardoso CR. Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study. J Hypertens 2013; 31(11): 2176-86.
[http://dx.doi.org/10.1097/HJH.0b013e328364103f] [PMID: 24029864]
[24]
Liu Y, Wang M, Morris AD, et al. Glycemic exposure and blood pressure influencing progression and remission of diabetic retinopathy: a longitudinal cohort study in GoDARTS. Diabetes Care 2013; 36(12): 3979-84.
[http://dx.doi.org/10.2337/dc12-2392] [PMID: 24170761]
[25]
Do DV, Wang X, Vedula SS, et al. Blood pressure control for diabetic retinopathy. Sao Paulo Med J 2015; 133(3): 278-9.
[http://dx.doi.org/10.1590/1516-3180.20151333T1] [PMID: 26176931]
[26]
Lobo C, Pires I, Alves D, Pappuru R, Ribeiro L, Cunha-Vaz J. Subclinical macular edema as a predictor of progression to central-involved macular edema in type 2 diabetes. Ophthalmic Res 2018; 60(1): 18-22.
[http://dx.doi.org/10.1159/000486792] [PMID: 29510401]
[27]
Willermain F, Scifo L, Weber C, Caspers L, Perret J, Delporte C. Potential interplay between hyperosmolarity and inflammation on retinal pigmented epithelium in pathogenesis of diabetic retinopathy. Int J Mol Sci 2018; 19(4): 1056.
[http://dx.doi.org/10.3390/ijms19041056] [PMID: 29614818]
[28]
Rangasamy S, McGuire PG, Franco Nitta C, Monickaraj F, Oruganti SR, Das A. Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy. PLoS One 2014; 9(10)e108508
[http://dx.doi.org/10.1371/journal.pone.0108508] [PMID: 25329075]
[29]
Stitt AW, Curtis TM, Chen M, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res 2016; 51: 156-86.
[http://dx.doi.org/10.1016/j.preteyeres.2015.08.001] [PMID: 26297071]
[30]
Ozawa GY, Bearse MA Jr, Adams AJ. Male-female differences in diabetic retinopathy? Curr Eye Res 2015; 40(2): 234-46.
[http://dx.doi.org/10.3109/02713683.2014.958500] [PMID: 25545999]
[31]
Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol 2016; 44(4): 260-77.
[http://dx.doi.org/10.1111/ceo.12696] [PMID: 26716602]
[32]
Solomon SD, Chew E, Duh EJ, et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care 2017; 40: 412-8.
[33]
Kansal A, Chouhan M, Singh N, Trikha S, Verghese J. Study of anemia in diabetes and its association with diabetic retinopathy. Int J Adv Med 2017; 4: 1437-40.
[http://dx.doi.org/10.18203/2349-3933.ijam20174299]
[34]
Foo V, Quah J, Cheung G, et al. HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics. J Diabetes 2017; 9(2): 200-7.
[http://dx.doi.org/10.1111/1753-0407.12403] [PMID: 27043025]
[35]
Hammes HP, Welp R, Kempe HP, et al. DPV Initiative—German BMBF Competence Network Diabetes Mellitus. Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database. PLoS One 2015; 10(7) e0132492
[http://dx.doi.org/10.1371/journal.pone.0132492] [PMID: 26177037]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 3
Year: 2020
Page: [242 - 247]
Pages: 6
DOI: 10.2174/1573399815666190215120435
Price: $65

Article Metrics

PDF: 20
HTML: 1